After the treatment of PD-1<sup>high</sup> T cells with nivolumab, the adhesion force with PD-L1<sup>+</sup> cancer cells increased to a similar level as with PD-L1<sup>-</sup> cancer cells. Here, CD274 is linked to cancer.